4.6 Editorial Material

At Issue: Cochrane, Early Intervention, and Mental Health Reform: Analysis, Paralysis, or Evidence-Informed Progress?

Journal

SCHIZOPHRENIA BULLETIN
Volume 38, Issue 2, Pages 221-224

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbr185

Keywords

early intervention; evidence-based medicine; mental health; psychosis

Categories

Ask authors/readers for more resources

Among the noncommunicable diseases, mental ill-health represents the major threat to social and economic progress because it impacts so powerfully on the most critical decades of life. Consequently, mental health reform is increasingly recognized as an urgent priority worldwide. This brings into sharp focus the role of evidence, and more specifically the Cochrane paradigm, in influencing decisions about health system reform. Cochrane clearly still has great value, especially in evidence-based medicine, where the focus is the evaluation of individual treatments. However, it cannot be allowed to be a dominant influence in evidence-based health care (EBHC) policy decisions for health system reform, unless it is modernized or complemented. Health services reform should definitely be as evidence-based as possible; however, the jury should consider its verdict on key reform proposals based on the balance of probabilities and informed by the best available evidence from all sources, not only randomized clinical trials, which in many domains may be never be feasible. This is particularly the case when reform is urgent, and the status quo has manifestly failed. So on the one hand, the evidence-based paradigm must not be misused to stifle or paralyze urgent reform. Alternatively, there is a real risk that, if we do not improve the sophistication of EBHC, the whole paradigm will be sidelined and reform will remain reactive, impulsive, and desultory. The recent Cochrane review on early intervention in psychosis provides an opportunity to consider these issues and their wider significance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychiatry

Cannabidiol for at risk for psychosis youth: A randomized controlled trial

G. Paul Amminger, Ashleigh Lin, Melissa Kerr, Amber Weller, Jessica Spark, Charlotte Pugh, Sally O'Callaghan, Maximus Berger, Scott R. Clark, James G. Scott, Andrea Baker, Iain McGregor, David Cotter, Zoltan Sarnyai, Andrew Thompson, Alison R. Yung, Brian O'Donoghue, Eoin Killackey, Cathy Mihalopoulos, Hok Pan Yuen, Barnaby Nelson, Patrick D. McGorry

Summary: This study aims to test the efficacy of CBD in treating subthreshold psychotic symptoms in the at-risk stage of psychotic disorder. Through a randomized controlled trial, CBD will be compared to placebo in improving positive psychotic symptoms in UHR patients, with the hypothesis that CBD will be significantly more effective.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Article Psychiatry

My child's future mental health: Carer's engagement with risk identification in an intervention study for youth with at-risk mental states

Michael Tham, Sarah Bendall, Thomas Carlyon-Stewart, Andrea Polari, Jessica Hartmann, Melissa Kerr, Paul Amminger, Patrick McGorry, Barnaby Nelson, Aswin Ratheesh

Summary: The study found that carers' experiences of their teenagers being identified as at-risk for psychosis varied, with main themes including limited or variable recall of risk information, perceived positive goal of risk disclosure, negative emotions associated with knowledge of risk, relief from uncertainty and helplessness, and effects of risk disclosure mediated by individual circumstance.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Article Psychiatry

Not in education, employment and training status in the early stages of bipolar I disorder with psychotic features

Sue M. Cotton, Kate M. Filia, Martin Lambert, Michael Berk, Aswin Ratheesh, Benno G. Schimmelmann, Craig Macneil, Melissa Hasty, Patrick D. McGorry, Philippe Conus

Summary: The study found that NEET status in young people with bipolar disorder and psychotic features is associated with premorbid decline, substance use, and forensic issues. NEET status can change during treatment, suggesting a need to further explore the effectiveness of vocational intervention programs specifically for BD.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Article Psychiatry

The clinical and functional outcomes of a large naturalistic cohort of young people accessing national early psychosis services

Ellie Brown, Caroline X. Gao, Heather Staveley, Georgia Williams, Simone Farrelly, Debra Rickwood, Nic Telford, Cerissa Papanastasiou, Pat McGorry, Andrew Thompson

Summary: This study analyzed the longitudinal changes in clinical and functional outcomes of individuals with first episode psychosis or at ultra-high risk of psychosis receiving services from headspace in Australia. Results showed significant improvement in both clinical and functional outcomes for all patients, with ultra-high risk patients showing greater reduction in distress symptoms and first episode psychosis patients experiencing greater reduction in positive psychosis symptoms. The study supports the use of real-world data to evaluate outcomes in early psychosis treatment and highlights the importance of ongoing functional recovery focus in these services.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2022)

Article Psychiatry

The incidence and admission rate for first-episode psychosis in young people before and during the COVID-19 pandemic in Melbourne, Australia

Brian O'Donoghue, Hannah Collett, Sophie Boyd, Yuanna Zhou, Emily Castagnini, Ellie Brown, Rebekah Street, Barnaby Nelson, Andrew Thompson, Patrick McGorry

Summary: The study found that the treated incidence of first-episode psychosis increased during the COVID-19 pandemic, especially in the later months of the restrictions. Additionally, the proportion of patients being involuntarily admitted to hospital significantly increased during the pandemic.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2022)

Article Immunology

The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial

Subash Raj Susai, David Mongan, Colm Healy, Mary Cannon, Barnaby Nelson, Connie Markulev, Miriam R. Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schloegelhofer, Stefan Smesny, Ian B. Hickie, Gregor E. Berger, Eric Y. H. Chen, Lieuwe de Haan, Dorien H. Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, Patrick D. McGorry, Melanie Focking, David Cotter, G. Paul Amminger

Summary: This study investigated the relationship of erythrocyte omega-3 FAs with plasma immune markers and examined whether the associations between omega-3 FAs and clinical outcomes were mediated via plasma immune markers in CHR individuals. The results indicate a predominantly anti-inflammatory relationship of omega-3 FAs on plasma inflammatory status in CHR individuals, but this did not appear to convey clinical benefits at 6 month and 12 month follow-up. Both immune and non-immune biological effects of omega-3 FAs would be resourceful in understanding the clinical benefits of omega-3 FAs in CHR population.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Psychiatry

Keyworker mediated enhancement of physical health in patients with first episode psychosis: A feasibility/acceptability study

John Broughan, Geoff McCombe, Jayleigh Lim, Donal O'Keeffe, Katherine Brown, Mary Clarke, Ciaran Corcoran, David Hanlon, Ned Kelly, John Lyne, Patrick McGorry, Sinead O' Brien, Karen O' Connor, Karen O' Mahony, Seamus Scott, Elizabeth Wycherley, Walter Cullen

Summary: This study evaluated a keyworker-mediated intervention promoting physical health among first episode psychosis patients, finding mixed feasibility outcomes and highlighting challenges such as low recruitment rates, variable linkages between keyworkers and general practitioners, and the impact of COVID-19 restrictions.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Article Psychiatry

Baseline data of a sequential multiple assignment randomized trial (STEP study)

Jessica A. Hartmann, Barnaby Nelson, Gunther Paul Amminger, Jessica Spark, Hok Pan Yuen, Melissa J. Kerr, Andrea Polari, Nicky Wallis, Julie Blasioli, Lisa Dixon, Cameron Carter, Rachel Loewy, Tara A. Niendam, Martha Shumway, Patrick D. McGorry

Summary: The aim of this study is to determine the most effective type, timing, and sequence of interventions in individuals at ultra-high risk of psychosis, and evaluate the acceptability and feasibility of the treatment approach through the recruitment flow and baseline clinical characteristics.

EARLY INTERVENTION IN PSYCHIATRY (2022)

Letter Medicine, General & Internal

Suicide by young Australians, 2006-2015: a cross-sectional analysis of national coronial data

Nicole T. M. Hill, Patrick D. McGorry, Jo Robinson

MEDICAL JOURNAL OF AUSTRALIA (2022)

Editorial Material Medicine, General & Internal

The reality of mental health care for young people, and the urgent need for solutions

Patrick D. McGorry

MEDICAL JOURNAL OF AUSTRALIA (2022)

Review Psychiatry

Outcomes for first-episode psychosis after entry via an at-risk mental state clinic compared to direct entry to a first episode of psychosis service: A systematic review and meta-analysis

Holly Sizer, Ellie Brown, Hellen Geros, Alison Yung, Barnaby Nelson, Patrick McGorry, Brian O'Donoghue

Summary: Limited research suggests similar or superior outcomes for individuals with a first episode of psychosis who present initially via an ARMS clinic. The reduced psychiatric admission rate is an important potential benefit of ARMS clinics that requires further validation.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Designing and scaling up integrated youth mental health care

Patrick D. McGorry, Cristina Mei, Andrew Chanen, Craig Hodges, Mario Alvarez-Jimenez, Eoin Killackey

Summary: Mental ill-health is the main threat to young people's health and future potential globally. The COVID-19 pandemic has worsened this trend. Despite the immense need, adolescents and emerging adults have limited access to mental health care. Co-designed strategies and innovations have emerged, including integrated primary youth mental health care services, but these need to be scaled up globally to meet the rising demand.

WORLD PSYCHIATRY (2022)

Article Psychiatry

Proportion and characteristics of young people in a first-episode psychosis clinic who first attended an at-risk mental state service or other specialist youth mental health service

Tara Burke, Andrew Thompson, Nathan Mifsud, Alison R. Yung, Barnaby Nelson, Patrick McGorry, Brian O'Donoghue

Summary: This study found that a significant proportion of young people initially attended other specialist youth mental health services, and these individuals had lower rates of hospital admission at the time of transition to first-episode psychosis.

SCHIZOPHRENIA RESEARCH (2022)

Article Psychiatry

Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis

Emily P. Hedges, Hannah Dickson, Stefania Tognin, Gemma Modinos, Mathilde Antoniades, Mark van der Gaag, Lieuwe de Haan, Patrick McGorry, Christos Pantelis, Anita Riecher-Rossler, Rodrigo Bressan, Neus Barrantes-Vidal, Marie-Odile Krebs, Merete Nordentoft, Stephan Ruhrmann, Gabriele Sachs, Bart P. Rutten, Jim van Os, Lucia R. Valmaggia, Philip McGuire, Matthew J. Kempton

Summary: Individuals with clinical high risk for psychosis show deficits in verbal memory and verbal fluency, which are related to longer-term outcomes of the disorder. These cognitive impairments are present even in those not taking antipsychotic medication. Furthermore, impaired immediate verbal recall predicts functional disability and non-remission from the clinical high risk state.

SCHIZOPHRENIA RESEARCH-COGNITION (2022)

No Data Available